JSPR - Jasper Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JSPR is currently covered by 5 analysts with an average price target of $58.68. This is a potential upside of $36.63 (166.12%) from yesterday's end of day stock price of $22.05.

Jasper Therapeutics's activity chart (see below) currently has 7 price targets and 28 ratings on display. The stock rating distribution of JSPR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 2.86% with an average time for these price targets to be met of 90.6 days.

Highest price target for JSPR is $80, Lowest price target is $65, average price target is $58.68.

Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 24-Oct-2024. First documented stock forecast 14-Oct-2021.

Best performing analysts who are covering JSPR - Jasper Therapeutics:

Judah Frommer Jay Olson Matthew Luchini Michael King Emily Bodnar

Currently out of the existing stock ratings of JSPR, 22 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$65

$42.95 (194.78%)

$65

30 days ago
(24-Oct-2024)

0/7 (0%)

$45.1 (226.63%)

Buy

$80

$57.95 (262.81%)

8 months 16 days ago
(07-Mar-2024)

0/2 (0%)

$53.3 (199.63%)

Buy

$40

$17.95 (81.41%)

$40

1 years 3 months 9 days ago
(14-Aug-2023)

1/7 (14.29%)

$26.7 (200.75%)

453

Buy

$68.5

$46.45 (210.66%)

$68.5

1 years 5 months 11 days ago
(12-Jun-2023)

0/7 (0%)

$52.3 (322.84%)

$19

$18.3 (2614.29%)

3 years 1 months 2 days ago
(21-Oct-2021)

0/1 (0%)

$5.75 (43.40%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is JSPR (Jasper Therapeutics) average time for price targets to be met?

On average it took 90.6 days on average for the stock forecasts to be realized with a an average price target met ratio 2.86

Which analyst has the current highest performing score on JSPR (Jasper Therapeutics) with a proven track record?

JUDAH FROMMER

Which analyst has the current lower performing score on JSPR (Jasper Therapeutics) with a proven track record?

EMILY BODNAR

Which analyst has the most public recommendations on JSPR (Jasper Therapeutics)?

Judah Frommer works at MORGAN STANLEY and has 5 price targets and 11 ratings on JSPR

Which analyst is the currently most bullish on JSPR (Jasper Therapeutics)?

Jay Olson with highest potential upside - $57.95

Which analyst is the currently most reserved on JSPR (Jasper Therapeutics)?

Judah Frommer with lowest potential downside - $17.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?